Phase I/II Study of Neoadjuvant Chemoradiotherapy Consisting of S-1 and Cisplatin for Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer (OGSG1205). - Shinkai M; Imano M; Yokokawa M; Tanaka R; Matsuyama J; Shimokawa T; Kawakami H; Satoh T; Yasuda T; Furukawa H (Annals of surgical oncology, 2025)